Our data presents a significant rise in the plasma levels of Ang2 in people with DN, which is in agreement with Tsai et al., who found a significant connection between elevated Ang2 levels and an increased risk of poor renal outcomes in patients with diabetic nephropathy [11]. The gene discussed is ANGPT2; the disease is liver dysplastic nodule.